Home › Funds › Sarissa Capital Management LP › REGN
Sarissa Capital Management LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
Sarissa Capital Management LP reported holding 4,190 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 1.47% of its reported portfolio and ranking #8 among its reported holdings. Sarissa Capital Management LP has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sarissa Capital Management LP's REGN position evolved
Sarissa Capital Management LP first disclosed a stake in REGN in Q3 2025 at 4,190 shares (US$2.4M). The position peaked in Q1 2026 at 4,190 shares, worth US$3.2M. Across 4 filings, Sarissa Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 4,190 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 4.19K | $2.36M | New |
| Q4 2025 | 4.19K | $3.23M | Hold |
| Q1 2026 | 4.19K | $3.24M | Hold |
| Q2 2026 | 4.19K | $2.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on Sarissa Capital Management LP
FAQ
How long has Sarissa Capital Management LP held REGN?
Sarissa Capital Management LP has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Sarissa Capital Management LP's current position in REGN?
As of Q2 2026, Sarissa Capital Management LP holds 4.19K shares of REGN (REGENERON PHARMACEUTICALS), valued at $2.61M, representing 1.47% of its reported portfolio and ranking #8.
Has Sarissa Capital Management LP been buying or selling REGN?
In the latest 13F filing (Q2 2026), Sarissa Capital Management LP held unchanged its position in REGN. The position peaked in Q1 2026 at 4.19K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.